Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Prepaid Assets: 2021-2024

Historic Prepaid Assets for Krystal Biotech (KRYS) over the last 4 years, with Dec 2024 value amounting to $11.7 million.

  • Krystal Biotech's Prepaid Assets rose 92.09% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 92.09%. This contributed to the annual value of $11.7 million for FY2024, which is 73.83% up from last year.
  • Krystal Biotech's Prepaid Assets amounted to $11.7 million in FY2024, which was up 73.83% from $6.7 million recorded in FY2023.
  • Krystal Biotech's Prepaid Assets' 5-year high stood at $11.7 million during FY2024, with a 5-year trough of $4.2 million in FY2021.
  • Its 3-year average for Prepaid Assets is $7.7 million, with a median of $6.7 million in 2023.
  • Data for Krystal Biotech's Prepaid Assets shows a peak YoY skyrocketed of 73.83% (in 2024) over the last 5 years.
  • Over the past 4 years, Krystal Biotech's Prepaid Assets (Yearly) stood at $4.2 million in 2021, then increased by 10.48% to $4.6 million in 2022, then soared by 45.53% to $6.7 million in 2023, then skyrocketed by 73.83% to $11.7 million in 2024.